Cancer Family
Malignant Thoracic Neoplasm
CI-CAN-00000256Explore in graph →
2,773 active trials51 approved drugs626 evidence items
- NCIt
- C3576
Loading cancer entity…
Cancer Family
CI-CAN-00000256Explore in graph →
Clinical trials
11,496 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,526)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02676050 | Visualising c-MET and Activated Neutrophils in Lung Cancer(DUAL) | terminated | Early Phase 1 | 5 | University of EdinburghOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT03348748 | Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer | terminated | Early Phase 1 | 20 | Roswell Park Cancer InstituteOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT04044872 | Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity | terminated | Early Phase 1 | 3 | University of Texas Southwestern Medical CenterOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT02748798 | Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders | terminated | Early Phase 1 | 10 | Thunder Bay Regional Health Research InstituteOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT03818776 | Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC | terminated | Early Phase 1 | 7 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT03870529 | High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer | terminated | Early Phase 1 | 20 | Wake Forest University Health SciencesOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT01707823 | Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer | terminated | Early Phase 1 | 4 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT01086696 | A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers | terminated | Early Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01413451 | Amatuximab for High Mesothelin Cancers | terminated | Early Phase 1 | 7 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01445054 | 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer | terminated | Early Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 11, 2019 | clinicaltrials |
| NCT01261299 | Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer | terminated | Early Phase 1 | 21 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT01034514 | 4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy | terminated | Early Phase 1 | 35 | Billy W. Loo Jr.OTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT02319889 | Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma | terminated | Early Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 1, 2017 | clinicaltrials |
| NCT01525446 | Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer | terminated | Early Phase 1 | 7 | Massachusetts General HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT00253461 | 11C Topotecan PET Imaging | terminated | Early Phase 1 | 7 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Jun 3, 2026source: clinicaltrials